Does the Pharmaceutical Sector Have a Coresponsibility for the Human Right to Health?

    Thumbnail
    Download
    Citations
    Scopus
    Web of Science
    Altmetric
    5
    2
    Author
    Schroeder, D
    Date
    2011-04-01
    Source Title
    Cambridge Quarterly of Healthcare Ethics
    Publisher
    CAMBRIDGE UNIV PRESS
    University of Melbourne Author/s
    Schroeder, Doris
    Affiliation
    School of Historical and Philosophical Studies
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Schroeder, D. (2011). Does the Pharmaceutical Sector Have a Coresponsibility for the Human Right to Health?. CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS, 20 (2), pp.298-308. https://doi.org/10.1017/S0963180110000952.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/33019
    DOI
    10.1017/S0963180110000952
    Description

    © 2011 Cambridge University Press. Online edition of the journal is available at http://journals.cambridge.org/action/displayJournal?jid=CQH
    Abstract
    <jats:p>The highest attainable standard of health is a fundamental human right, which has been part of international law since 1948. States and their institutions are the primary duty bearers responsible for ensuring that human rights are respected, protected, and fulfilled. However, more recently it has been argued that pharmaceutical companies have a coresponsibility to fulfill the human right to health. Most prominently, this coresponsibility has been expressed in the United Nations (UN) Millennium Goal 8 Target 4. “In cooperation with pharmaceutical companies, provide access to affordable essential drugs in developing countries.”</jats:p>
    Keywords
    global ethics; medicine; intellectual property rights

    Export Reference in RIS Format     

    Collections